Abstract Introduction: HIV infection predisposes to hypercoagulable state, it has been recognized as an independent risk factor for venous thromboembolism. Material and Methods: This is retrospective descriptive study of clinical profile and treatment outcome in HIV infection with venous thromboembolism. Study period: Feb. 2012 to 31 Jan 2015, during this period total 595 patients with HIV infection admitted in BVDUMC and H Sangli. Among this, was case series study of 8 patient had the diagnosis of venous thromboembolism, diagnosed by arteriovenous doppler study. The results of this study suggest HIV infection potentially develops venous thromboembolism (DVT), 2-10 times commoner in HIV infection than without HIV infection. Significant correlation between thrombotic disease and CD4+ count <200, as well as in the younger age group i.e. Age less than <45 years and mainly in females. Conclusion: Development of DVT in AIDS/HIV infection needs high index of suspicion to prevent, development of serious complication like PE, so as to prevent morbidity and mortality due to AIDS/HIV infection with VTE. Treatment is as per ACCP guidelines inj. Heparin (LMWH) sc bid for 5 days and oral anticoagulant Tab warfarin 5mg once a day or Dabigatran150mg twice a day continued for 6 months, monitoring with target INR between 2 to 2.5.

Keywords: Venous Thromboembolism, HIV/AIDS, DVT, Heparine.